A. Wallensten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
A. Wallensten has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Isabel Oliver
UK Health Security Agency, London, UK
2 shared publications D Lewis
Health Protection Agency South West, Regional Epidemiology Unit, Stonehouse, United Kingdom
1 shared publicationI. Brown
EU/OIE/FAO International Reference Laboratory for Avian Influenza and Newcastle Disease, Weybridge, UK
1 shared publicationK. Hoschler
Health Protection Agency, Virus Reference Department, Centre for Infection, Colindale, UK
1 shared publicationM. Salter
Health Protection Agency, South West, Dorset Health Protection Team, Ferndown, UK
1 shared publicationS. Bennett
Health Protection Agency, South West, Dorset Health Protection Team, Ferndown, UK
1 shared publication
Latest Publications
- 18 September 2009
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 138 (2) , 210-213
No evidence of transmission of H5N1 highly pathogenic avian influenza to humans after unprotected contact with infected wild swans
SUMMARY: Highly pathogenic avian influenza (HPAI) subtype H5N1 remains a public health threat as long as it circulates in wild and domestic birds. Information on the transmissibility of H5N1 HPAI from wild birds is needed for evidence-based public health advice. We investigated if transmission of H5N1 HPAI had taken place in people that had unprotected contact with infected wild mute swans during an incident at the Abbotsbury Swannery in Dorset, England. Thirteen people who had been exposed to infected swans were contacted and actively followed up for symptoms. Serology was taken after 30 days. We did not find evidence of transmission of H5N1 HPAI to humans during the incident. The incident provided a rare opportunity to study the transmissibility of the virus from wild birds to humans.
- 18 September 2009
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 138 (2) , 210-213
No evidence of transmission of H5N1 highly pathogenic avian influenza to humans after unprotected contact with infected wild swans
SUMMARY: Highly pathogenic avian influenza (HPAI) subtype H5N1 remains a public health threat as long as it circulates in wild and domestic birds. Information on the transmissibility of H5N1 HPAI from wild birds is needed for evidence-based public health advice. We investigated if transmission of H5N1 HPAI had taken place in people that had unprotected contact with infected wild mute swans during an incident at the Abbotsbury Swannery in Dorset, England. Thirteen people who had been exposed to infected swans were contacted and actively followed up for symptoms. Serology was taken after 30 days. We did not find evidence of transmission of H5N1 HPAI to humans during the incident. The incident provided a rare opportunity to study the transmissibility of the virus from wild birds to humans.
- Open Access
- 30 July 2009
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 14 (30) , 19285
Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England
School closure along with mass prophylactic oseltamivir treatment of pupils have been used in England and elsewhere to contain school outbreaks of influenza A(H1N1)v. We evaluated the protective effect, compliance with and side effects of oseltamivir chemoprophylactic treatment with a ten-day course of 1x 75mg given to 11-12-year-old pupils in one school year in a secondary school in South West England closed for ten days in response to a symptomatic laboratory-confirmed pupil. We distributed a questionnaire to pupils in the affected school year in class after the school had re-opened. Questions included symptoms of flu-like illness, compliance with chemoprophylaxis and side effects. All present on the day, 248 (93.2%) participated. Compliance with chemoprophylaxis was high, 77% took the full course, 91% took at least seven days. Fifty-one percent experienced symptoms such as feeling sick (31.2%), headaches (24.3%) and stomach ache (21.1%). Although some children were ill with flu-like symptoms, those tested did not have A(H1N1)v infection. Compliance with oseltamivir chemoprophylaxis was high, although likely side effects were common. The burden of side effects needs to be considered when deciding on mass oseltamivir chemoprophylaxis in children especially given that the symptoms of A(H1N1)v influenza are generally mild.
- 30 July 2009
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 14 (30) , 19285
Open AccessCompliance and side effects of prophylactic oseltamivir treatment in a school in South West England
School closure along with mass prophylactic oseltamivir treatment of pupils have been used in England and elsewhere to contain school outbreaks of influenza A(H1N1)v. We evaluated the protective effect, compliance with and side effects of oseltamivir chemoprophylactic treatment with a ten-day course of 1x 75mg given to 11-12-year-old pupils in one school year in a secondary school in South West England closed for ten days in response to a symptomatic laboratory-confirmed pupil. We distributed a questionnaire to pupils in the affected school year in class after the school had re-opened. Questions included symptoms of flu-like illness, compliance with chemoprophylaxis and side effects. All present on the day, 248 (93.2%) participated. Compliance with chemoprophylaxis was high, 77% took the full course, 91% took at least seven days. Fifty-one percent experienced symptoms such as feeling sick (31.2%), headaches (24.3%) and stomach ache (21.1%). Although some children were ill with flu-like symptoms, those tested did not have A(H1N1)v infection. Compliance with oseltamivir chemoprophylaxis was high, although likely side effects were common. The burden of side effects needs to be considered when deciding on mass oseltamivir chemoprophylaxis in children especially given that the symptoms of A(H1N1)v influenza are generally mild.